Technical Analysis for LUMO - Lumos Pharma, Inc.

Grade Last Price % Change Price Change
B 4.32 -0.23% -0.01
LUMO closed down 0.23 percent on Wednesday, November 20, 2024, on 1.17 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction -0.23%
Narrow Range Bar Range Contraction -0.23%
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Inside Day Range Contraction 0.00%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 19 hours ago
Fell Below Lower Bollinger Band about 19 hours ago
Rose Above 10 DMA 2 days ago
10 DMA Resistance 2 days ago
1.5x Volume Pace 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lumos Pharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for severe, rare, and genetic diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone stimulating small molecule, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency. The company has a licensing agreement with Ellipses Pharma Limited for the development of and rights to commercialize nanoparticle formulations of two therapeutics for oncology indications. Lumos Pharma, Inc. was founded in 2011 and is headquartered in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmacy Genetic Diseases Growth Hormone Growth Hormone Deficiency Growth Hormone Therapy

Is LUMO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.5756
52 Week Low 1.3701
Average Volume 72,057
200-Day Moving Average 2.99
50-Day Moving Average 4.06
20-Day Moving Average 4.36
10-Day Moving Average 4.33
Average True Range 0.14
RSI (14) 55.95
ADX 11.2
+DI 16.38
-DI 13.06
Chandelier Exit (Long, 3 ATRs) 4.15
Chandelier Exit (Short, 3 ATRs) 4.35
Upper Bollinger Bands 4.44
Lower Bollinger Band 4.28
Percent B (%b) 0.26
BandWidth 3.79
MACD Line 0.09
MACD Signal Line 0.12
MACD Histogram -0.0289
Fundamentals Value
Market Cap 34.19 Million
Num Shares 7.91 Million
EPS -3.99
Price-to-Earnings (P/E) Ratio -1.08
Price-to-Sales 13.74
Price-to-Book 0.67
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.35
Resistance 3 (R3) 4.35 4.35 4.35
Resistance 2 (R2) 4.35 4.34 4.35 4.34
Resistance 1 (R1) 4.33 4.33 4.33 4.33 4.34
Pivot Point 4.33 4.33 4.33 4.33 4.33
Support 1 (S1) 4.31 4.32 4.31 4.31 4.30
Support 2 (S2) 4.31 4.31 4.31 4.30
Support 3 (S3) 4.29 4.31 4.30
Support 4 (S4) 4.29